Ten experts, including our CEO, Jean Drouin, MD, contributed to the November issue of PM360, “Data Overload—The Best Ways to Manage and Interpret Data.” Experts from across the life sciences industry shared their point of view on what it will take to use the right data at the right time. Jean zoomed in on the micro-targeting trend happening within the commercialization organization. Today, brand teams are asking more nuanced questions about their target patients and HCPs than ever before. They are turning to companies like Clarify, to raise the bar for the precision and speed with which real-world commercial insights can be delivered. Get the full story here. To learn more about Clarify’s software for Life Sciences helps companies from the top 20 pharma to specialty biotechs with launch planning and market tracking, click here.
Life Science Insights | November 11, 2020
Clarify’s CEO talks with PM360 about pharma brand teams raising the bar
Reporting that’s committed to making healthcare insights accessible to all.
The complexity of healthcare data. Clarified.
Made for your most precise decision-making yet. Introducing the Clarify Atlas Platform®, our healthcare analytics platform and the foundation underpinning each of our building blocks. Atlas powers every decision with clarity brought from 20 billion data points and our best-in-class benchmarking technology.
Made for your most precise decision-making yet. Introducing the Clarify Atlas Platform®, our healthcare analytics platform and the foundation underpinning each of our building blocks. Atlas powers every decision with clarity brought from 20 billion data points and our best-in-class benchmarking technology.